Alpha Laboratories has entered into a strategic partnership with Clinical Design Technologies to market and support that company's digital closed urine testing system. This innovative technology offers unmatched clinical efficacy, simplicity, and accuracy, setting a new standard for urinalysis at the point of care.
Clinical Design Technologies’ UTS (urine testing system) is designed to deliver very fast, ‘Right First Time’ urinalysis results, streamlining the testing process and providing healthcare professionals with accurate and reliable data. Its advanced technology ensures precise results, empowering informed decision making, enhancing clinical outcomes, and optimising resource allocation. This not only improves multiple patient-care pathways but also reduces costs and releases valuable healthcare time and resources.
"We are thrilled to partner with Clinical Design Technologies to bring this groundbreaking innovation to our clinical customers and additional markets," said Rob Vint, Managing Director of Alpha Laboratories. "The UTS system represents a significant advancement in urinalysis, providing unparalleled accuracy and efficiency at the point of care."
"This collaboration with Alpha Laboratories is a transformational step forward in urine testing. Leveraging Alpha’s highly respected market position will enable our advanced diagnostic technology to benefit patients from acute to community care, through its simplicity and accuracy," said Daniel Bee, CEO of Clinical Design Technologies. "The partnership between our two leading British diagnostic specialists will enhance clinical productivity and efficacy across UK healthcare and beyond. Reducing costs and time to diagnosis, it will improve the efficiency of healthcare services and positively impact patients."
Rob Vint and Daniel Bee are pictured above signing the agreement.
Both companies will be exhibiting at the upcoming Clinical Diagnostics Expo.
For more information about Clinical Design please visit clinical.design.